Dipeptidyl peptidase-4 inhibitor: Sitagliptin down-regulated toll-like receptor 4 signaling pathway to reduce uterine injury in rats

Document Type : Original Article

Authors

1 Department of Pharmacology, Faculty of Medicine, Minia University, Minia, Egypt

2 Department of Pharmacology, Faculty of Pharmacy, Deraya University, Minia, Egypt

3 Depatment of Human Anatomy and Embryology, Faculty of Medicine, Minia University, delegated to Deraya University-New Minia City, Egypt

4 Department of Obstetrics and Gynecology, Faculty of Medicine, Minia University. Minia, Egypt

5 Department of Forensic medicine and clinical toxicology, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt

Abstract

Objective(s): Uterine ischemia is a common problem with ongoing controversy about its pathogenesis and prevention. The present study aimed to investigate the protective role of sitagliptin against uterine ischemia-reperfusion injury (IRI). 
Materials and Methods: Rats were allocated into 4 groups: control, sitagliptin (SIT) (5 mg/kg), IR; ischemia was induced followed by reperfusion, and IR+SIT; SIT was administered 1 hr before IRI. Uteri were removed for histopathological and biochemical observations. Malondialdehyde (MDA), total nitrites (NOx), reduced glutathione (GSH), superoxide dismutase (SOD) activity, tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and toll-like receptor 4 (TLR4) were all measured. Hematoxylin and eosin (H&E) stain, Periodic acid-Schiff stain (PAS), and caspase-3 immunostaining were applied. 
Results: In the IR+SIT group; NOx, GSH, and SOD activities increased significantly. Meanwhile, the levels of MDA, TNF-α, IL-6, TLR4, and caspase-3 immunoexpression showed a significant reduction, as compared with the IR group. In the IR+SIT group, an improvement in the histopathological picture was noticed.
Conclusion: The results showed that sitagliptin confers protection against uterine IRI through anti-oxidant, anti-inflammatory, and anti-apoptotic effects with a possible role for TLR4.

Keywords

References

1. Gosden RG. Ovary and uterus transplantation. Reproduction 2008; 136: 671-680.
2. Ly A, Mills AM, McKenney JK, Balzer BL, Kempson RL, Hendrickson MR, et al. Atypical leiomyomas of the uterus: A clinicopathologic study of 51 cases. Am J Surg Pathol 2013; 37: 643-649.
3. Halladin NL. Oxidative and inflammatory biomarkers of ischemia and reperfusion injuries. Dan Med J 2015; 62: B5054.
4. Abdelzaher WY, Rofaeil RR, Ali DME, Attya ME. Protective effect of dipeptidyl peptidase-4 inhibitors in testicular torsion/detorsion in rats: A possible role of HIF-1α and nitric oxide. Naunyn Schmiedebergs Arch Pharmacol 2020; 393: 603-614.
5. Breen AP, Murphy JA. Reactions of oxyl radicals with DNA. Free Radic Biol Med 1995; 18: 1033-1077.
6. Dogan H, Timurkaan N, Saat N, Seker I, Risvanli A. A new animal model for uterine torsion and uterine ischemia-reperfusion studies, but not fetal hypoxia studies. Animal Model Exp Med 2018; 1: 242-245.
7. Arumugam TV, Okun E, Tang SC, Thundyil J, Taylor SM, Woodruff TM. Toll-like receptors in ischemia-reperfusion injury. Shock (Augusta, Ga) 2009; 32: 4-16.
8. Gonzalez J, Xu H, Ofori E, Elovitz M. Toll-like receptors in the uterus, cervix, and placenta: is pregnancy an immunosuppressed state? Am J Obstet Gynecol 2007; 197: 296.e1-.e6.
9. Abdel-Gaber SA, Geddawy A, Moussa RA. The hepatoprotective effect of sitagliptin against hepatic ischemia reperfusion-induced injury in rats involves the Nrf-2/HO-1 pathway. Pharmacol Rep 2019; 71: 1044-1049.
10. Chang MW, Chen CH, Chen YC, Wu YC, Zhen YY, Leu S, et al. Sitagliptin protects rat kidneys from acute ischemia-reperfusion injury via upregulation of GLP-1 and GLP-1 receptors. Acta Pharmacol Sin 2015; 36: 119-130.
11. Khedr RM, Ahmed AAE, Kamel R, Raafat EM. Sitagliptin attenuates intestinal ischemia/reperfusion injury via cAMP/PKA, PI3K/Akt pathway in a glucagon-like peptide 1 receptor-dependent manner. Life Sci 2018; 211: 31-39.
12. Li Y, Lv X, Jiang M, Jin Z. Sitagliptin ameliorates hypoxia-induced damages in endometrial stromal cells: An implication in endometriosis. Bioengineered 2022; 13: 800-809.
13. Marcondes FK, Bianchi FJ, Tanno AP. Determination of the estrous cycle phases of rats: Some helpful considerations. Braz J Biol 2002; 62: 609-614.
14. Youssef MI, Mahmoud AA, Abdelghany RH. A new combination of sitagliptin and furosemide protects against remote myocardial injury induced by renal ischemia/reperfusion in rats. Biochem Pharmacol 2015; 96: 20-29.
15. Atalay YO, Aktas S, Sahin S, Kucukodaci Z, Ozakpinar OB. Remifentanil protects uterus against ischemia-reperfusion injury in rats. Acta Cir Bras 2015; 30: 756-761.
16. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978; 52: 302-310.
17. Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974; 47: 469-474.
18. Sastry KV, Moudgal RP, Mohan J, Tyagi JS, Rao GS. Spectrophotometric determination of serum nitrite and nitrate by copper-cadmium alloy. Anal Biochem 2002; 306: 79-82.
19. Aziz NM, Elbassuoni EA, Kamel MY, Ahmed SM. Hydrogen sulfide renal protective effects: Possible link between hydrogen sulfide and endogenous carbon monoxide in a rat model of renal injury. Cell Stress Chaperon 2020; 25: 211-221.
20. Ahmed SM, Abdelzaher WY. Zafirlukast alleviates ovarian histological and biochemical alterations induced by ischemia-reperfusion in rats. Kasr Al Ainy Med J 2016; 22: 129.
21. Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O. Oxidative stress and antioxidant defense. World Allergy Organ J 2012; 5: 9-19.
22. Ersoy Canillioglu Y, Erkanli Senturk G. Alterations of IL-1 and VEGF After Ischemia-Reperfusion Injured Uterus and Ovary in Rats. Medeni med J 2020; 35: 106-115.
23. Aslan M, Erkanli Senturk G, Akkaya H, Sahin S, Yılmaz B. The effect of oxytocin and Kisspeptin-10 in ovary and uterus of ischemia-reperfusion injured rats. Taiwan J Obstet Gynecol 2017; 56: 456-462.
24. Chang G, Zhang P, Ye L, Lu K, Wang Y, Duan Q, et al. Protective effects of sitagliptin on myocardial injury and cardiac function in an ischemia/reperfusion rat model. Eur J Pharmacol 2013; 718: 105-113.
25. El-Sahar AE, Safar MM, Zaki HF, Attia AS, Ain-Shoka AA. Sitagliptin attenuates transient cerebral ischemia/reperfusion injury in diabetic rats: implication of the oxidative-inflammatory-apoptotic pathway. Life Sci 2015; 126: 81-86.
26. Trocha M, Krzystek-Korpacka M, Merwid-Ląd A, Nowak B, Pieśniewska M, Dzięgiel P, et al. Sitagliptin-dependent differences in the intensity of oxidative stress in rat livers subjected to ischemia and reperfusion. Oxid Med Cell Longev 2019; 2019: 2738605.
27. Saat N, Risvanli A, Dogan H, Onalan E, Akpolat N, Seker I, et al. Effect of melatonin on torsion and reperfusion induced pathogenesis of rat uterus. Biotech Histochem 2019; 94: 533-539.
28. Sahin Ersoy G, Kurek Eken M, Cevik O, Cilingir OT, Tal R. Mycophenolate mofetil attenuates uterine ischaemia/reperfusion injury in a rat model. Reprod Biomed 2017; 34: 115-123.
29. Liu YX, Jin LM, Zhou L, Xie HY, Jiang GP, Wang Y, et al. Mycophenolate mofetil attenuates liver ischemia/reperfusion injury in rats. Transpl Int 2009; 22: 747-756.
30. Hu J, Yuan R. Decreased expression of c-kit and telomerase in a rat model of chronic endometrial ischemia. Med Sci Monit 2011; 17: 103-109.
31. Gluba A, Banach M, Hannam S, Mikhailidis DP, Sakowicz A, Rysz J. The role of Toll-like receptors in renal diseases. Nat Rev Nephrol 2010; 6: 224-235.
32. Johnson GB, Brunn GJ, Tang AH, Platt JL. Evolutionary clues to the functions of the Toll-like family as surveillance receptors. Trends Immunol 2003; 24: 19-24.
33. Tsan MF, Gao B. Endogenous ligands of Toll-like receptors. J Leukoc Biol 2004; 76: 514-519.
34. Wu H, Chen G, Wyburn KR, Yin J, Bertolino P, Eris JM, et al. TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Investig 2007; 117: 2847-2859.
35. Chen J, John R, Richardson JA, Shelton JM, Zhou XJ, Wang Y, et al. Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injury. Kidney Int 2011; 79: 288-299.
36. Ben Mkaddem S, Pedruzzi E, Werts C, Coant N, Bens M, Cluzeaud F, et al. Heat shock protein gp96 and NAD(P)H oxidase 4 play key roles in Toll-like receptor 4-activated apoptosis during renal ischemia/reperfusion injury. Cell Death Differ 2010; 17: 1474-1485.
37. Sun Z, Zhao T, Lv S, Gao Y, Masters J, Weng H. Dexmedetomidine attenuates spinal cord ischemia-reperfusion injury through both anti-inflammation and anti-apoptosis mechanisms in rabbits. J Transl Med 2018; 16: 209.
38. Merry HE, Phelan P, Doak MR, Zhao M, Hwang B, Mulligan MS. Role of toll-like receptor-4 in lung ischemia-reperfusion injury. Ann Thorac Surg 2015; 99: 1193-1199.
39. Palma-Tortosa S, Hurtado O, Pradillo JM, Ferreras-Martín R, García-Yébenes I, García-Culebras A, et al. Toll-like receptor 4 regulates subventricular zone proliferation and neuroblast migration after experimental stroke. Brain Behav Immun 2019; 80: 573-582.
40. Wang J, Xu Z, Chen X, Li Y, Chen C, Wang C, et al. MicroRNA-182-5p attenuates cerebral ischemia-reperfusion injury by targeting Toll-like receptor 4. Biochem Biophys Res Commun 2018; 505: 677-684.
Iranian Journal of Basic Medical Sciences
Volume 25, Issue 11
November 2022
Pages 1396-1401

Files

Share

How to cite

Statistics